Montegrande, Marilou S.
HRN: 22-59-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/16/2023
CEFUROXIME 500MG (TAB)
02/16/2023
02/23/2023
PO
500mg
BID X 7 Days
UTI; Pus Cells: 9-12
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes